Cargando…

Efficacy of Different Progestins in Women With Advanced Endometriosis Undergoing Controlled Ovarian Hyperstimulation for in vitro Fertilization-A Single-Center Non-inferiority Randomized Controlled Trial

Object: Is it possible to use different progestins cotreatment with human menopausal gonadotrophin (hMG) in women with advanced endometriosis but normal ovulation during controlled ovarian hyperstimulation (COH) in vitro fertilization (IVF)? Whether different progestins treatments can be an alternat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Haiyan, Li, Jianghui, Shen, Xi, Cong, Yanyan, Wang, Yun, Wu, Ling, Li, Bin, Gao, Hongyuan, Ma, Meng, Zhang, Wei, Mao, Xiaoyan, Fu, Yonglun, Lyu, Qifeng, Chai, Weiran, Kuang, Yanping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103634/ https://www.ncbi.nlm.nih.gov/pubmed/32265834 http://dx.doi.org/10.3389/fendo.2020.00129

Ejemplares similares

Use of medroxyprogesterone acetate in women with ovarian endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization
por: Guo, Haiyan, et al.
Publicado: (2017)

Impacts of medroxyprogesterone acetate on oocytes and embryos: matched case-control study in women with stage III–IV ovarian endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization
por: Guo, Haiyan, et al.
Publicado: (2020)

Metabolomics analysis of follicular fluid in ovarian endometriosis women receiving progestin-primed ovary stimulation protocol for in vitro fertilization
por: Guo, Haiyan, et al.
Publicado: (2023)

Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders
por: Chen, Qiuju, et al.
Publicado: (2017)

Lipidomic Components Alterations of Human Follicular Fluid Reveal the Relevance of Improving Clinical Outcomes in Women Using Progestin-Primed Ovarian Stimulation Compared to Short-Term Protocol
por: Wen, Xiaowei, et al.
Publicado: (2018)

Effect of Natural Cycle Endometrial Preparation for Frozen-Thawed Embryo Transfer in Patients with Advanced Endometriosis
por: Guo, Haiyan, et al.
Publicado: (2016)

Progestin vs. Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surges in Poor Responders Undergoing in vitro Fertilization Treatment: A Randomized Controlled Trial
por: Chen, Qiuju, et al.
Publicado: (2019)

Quercetin prevents primordial follicle loss via suppression of PI3K/Akt/Foxo3a pathway activation in cyclophosphamide-treated mice
por: Li, Jianghui, et al.
Publicado: (2021)

Effect of Switching from a Progestin-Primed Ovarian Stimulation Protocol to a Modified Ultra-Long Protocol Among Women Who Had 1 Progestin-Primed Ovarian Stimulation (PPOS) Failure Verses Those Who Had 2 PPOS Failures
por: Shen, Xi, et al.
Publicado: (2020)

Role of suppression of endometriosis with progestins before IVF-ET: a non-inferiority randomized controlled trial
por: Khalifa, Eissa, et al.
Publicado: (2021)

The effect of human chorionic gonadotrophin contained in human menopausal gonadotropin on the clinical outcomes during progestin-primed ovarian stimulation
por: Zhu, Xiuxian, et al.
Publicado: (2017)

Effect of Frozen Embryo Transfer and Progestin-primed Ovary Stimulation on IVF outcomes in women with high body mass index
por: Wang, Li, et al.
Publicado: (2017)

Utrogestan as an Effective Oral Alternative for Preventing Premature Luteinizing Hormone Surges in Women Undergoing Controlled Ovarian Hyperstimulation for In Vitro Fertilization
por: Zhu, Xiuxian, et al.
Publicado: (2015)

A Higher Estradiol Rise After Dual Trigger in Progestin-Primed Ovarian Stimulation Is Associated With a Lower Oocyte and Mature Oocyte Yield in Normal Responders
por: Huang, Jialyu, et al.
Publicado: (2019)

Progestin-primed milder stimulation with clomiphene citrate yields fewer oocytes and suboptimal pregnancy outcomes compared with the standard progestin-primed ovarian stimulation in infertile women with polycystic ovarian syndrome
por: Ye, Hongjuan, et al.
Publicado: (2018)

Live-Birth Outcomes and Congenital Malformations After Progestin-Primed Ovarian Stimulation in Maternal Endometriosis
por: Liang, Zhou, et al.
Publicado: (2020)

Neonatal outcomes and congenital malformations in children born after progestin-primed ovarian stimulation protocol
por: Li, Danjun, et al.
Publicado: (2022)

Comparison of neonatal outcomes and live-birth defects after progestin-primed ovarian stimulation versus conventional ovarian stimulation for in vitro fertilization: A large retrospective cohort study
por: Wang, Ningling, et al.
Publicado: (2018)

Differences in Ectopic Pregnancy Rates between Fresh and Frozen Embryo Transfer after In Vitro Fertilization: A Large Retrospective Study
por: Hu, Zhijie, et al.
Publicado: (2022)

The role of combining medroxyprogesterone 17-acetate with human menopausal gonadotropin in mouse ovarian follicular development
por: Wen, Xiaowei, et al.
Publicado: (2018)

Progestin-Primed Ovarian Stimulation with Dydrogesterone versus Medroxyprogesterone Acetate in Women with Polycystic Ovarian Syndrome for in vitro Fertilization: A Retrospective Cohort Study
por: Huang, Jialyu, et al.
Publicado: (2019)

Optimal Ovulation Trigger–Oocyte Pickup Interval in Progestin-Primed Ovarian Stimulation Protocol: A Retrospective Study Using Propensity Score Matching
por: Shen, Xi, et al.
Publicado: (2019)

Effects of Progestin on Modulation of the Expression of Biomarkers in Endometriosis
por: Matasariu, Daniela Roxana, et al.
Publicado: (2023)

A delayed ovulation of progestin-primed ovarian stimulation (PPOS) by downregulating the LHCGR/PGR pathway
por: Xie, Yating, et al.
Publicado: (2023)

The comparison of two different protocols ultra-long versus medroxyprogesterone acetate in women with ovarian endometriosis: a prospective randomized controlled trial
por: Guo, Haiyan, et al.
Publicado: (2022)

Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols
por: Mathieu d’Argent, Emmanuelle, et al.
Publicado: (2020)

Controlled ovarian hyperstimulation for fertility preservation in women with breast cancer: Practical issues
por: Park, So Yun, et al.
Publicado: (2021)

Pregnancy Rate after Controlled Ovarian Hyperstimulation and Intrauterine Insemination for the Treatment of Endometriosis following Surgery
por: Keresztúri, Attila, et al.
Publicado: (2015)

The Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments
por: Zhu, Xiuxian, et al.
Publicado: (2016)

Fertility and Neonatal Outcomes of Freeze-All vs. Fresh Embryo Transfer in Women With Advanced Endometriosis
por: Wu, JIayi, et al.
Publicado: (2019)

Luteinizing Hormone Suppression by Progestin-Primed Ovarian Stimulation Is Associated With Higher Implantation Rate for Patients With Polycystic Ovary Syndrome Who Underwent in vitro Fertilization/Intracytoplasmic Sperm Injection Cycles: Comparing With Short Protocol
por: Chen, Chen, et al.
Publicado: (2022)

Progestins in the symptomatic management of endometriosis: a meta-analysis on their effectiveness and safety
por: Mitchell, Jon-Benay, et al.
Publicado: (2022)

Anti-müllerian Hormone for the Prediction of Ovarian Response in Progestin-Primed Ovarian Stimulation Protocol for IVF
por: Huang, Jialyu, et al.
Publicado: (2019)

Decrease in preovulatory serum estradiol is a valuable marker for predicting premature ovulation in natural/unstimulated in vitro fertilization cycle
por: Lu, Xuefeng, et al.
Publicado: (2018)

The Progestin Revolution: progestins are arising as the dominant players in the tight interlink between contraceptives and bleeding control
por: Shoupe, Donna
Publicado: (2021)

Renal and Hepatic Functions after A Week of Controlled Ovarian Hyperstimulation during In Vitro Fertilization Cycles
por: Romito, Ilaria, et al.
Publicado: (2017)

Severe Ovarian Hyperstimulation Syndrome in the Setting of In Vitro Fertilization Treatment
por: Diaz Ayllon, Hannia, et al.
Publicado: (2023)

Combined 17β-Estradiol with TCDD Promotes M2 Polarization of Macrophages in the Endometriotic Milieu with Aid of the Interaction between Endometrial Stromal Cells and Macrophages
por: Wang, Yun, et al.
Publicado: (2015)

Tolerability of endometriosis medical treatment: a comparison between combined hormonal contraceptives and progestins
por: da Costa Pinheiro, Denise Joffily Pereira, et al.
Publicado: (2023)

Neonatal outcomes and congenital malformations in children born after dydrogesterone application in progestin-primed ovarian stimulation protocol for IVF: a retrospective cohort study
por: Huang, Jialyu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1j7g9perhbsla0fe4lknhbi1q0